Notable effects of angiotensin II receptor blocker, valsartan, on acute cardiotoxic changes after standard chemotherapy with cyclophosphamide, doxorubicin …
H Nakamae, K Tsumura, Y Terada… - … Journal of the …, 2005 - Wiley Online Library
BACKGROUND There are three distinct types of doxorubicin‐induced cardiotoxicity (acute,
chronic, and late‐onset). Although previous studies with animal models suggest that …
chronic, and late‐onset). Although previous studies with animal models suggest that …
Risk factor analysis for thrombotic microangiopathy after reduced‐intensity or myeloablative allogeneic hematopoietic stem cell transplantation
H Nakamae, T Yamane, T Hasegawa… - American journal of …, 2006 - Wiley Online Library
Thrombotic microangiopathy (TMA) impairs long‐term survival after allogeneic hematopoietic
stem cell transplantation (HSCT). As the allogeneic HSCT procedure has developed, …
stem cell transplantation (HSCT). As the allogeneic HSCT procedure has developed, …
Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib
Y Hayashi, H Nakamae, T Katayama… - Leukemia & …, 2012 - Taylor & Francis
Immunomodulation induced by dasatinib is reportedly related to better prognosis in chronic
myeloid leukemia (CML). However, the underlying mechanism has not yet been fully …
myeloid leukemia (CML). However, the underlying mechanism has not yet been fully …
[HTML][HTML] Early elevation of complement factor ba is a predictive biomarker for transplant-associated thrombotic microangiopathy
H Okamura, H Nakamae, T Shindo, K Ohtani… - Frontiers in …, 2021 - frontiersin.org
Transplant-associated thrombotic microangiopathy (TA-TMA) is a fatal complication after
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Previous reports suggest that …
allogeneic hematopoietic stem cell transplantation (allo-HSCT). Previous reports suggest that …
Safety and efficacy of anti-programmed cell death-1 monoclonal antibodies before and after allogeneic hematopoietic cell transplantation for relapsed or refractory …
…, T Takemura, S Terakura, H Iida, M Nakamae… - International journal of …, 2020 - Springer
We conducted a multicenter study on anti-programmed cell death-1 monoclonal antibodies (anti-PD-1
mAbs) before/after allogeneic hematopoietic cell transplantation (allo-HCT) for …
mAbs) before/after allogeneic hematopoietic cell transplantation (allo-HCT) for …
A prospective observational study of immune reconstitution following transplantation with post‐transplant reduced‐dose cyclophosphamide from HLA‐haploidentical …
H Nakamae, K Fujii, S Nanno, H Okamura… - Transplant …, 2019 - Wiley Online Library
Allogeneic hematopoietic cell transplantation ( HCT ) from HLA ‐haploidentical donors with
post‐transplantation high‐dose cyclophosphamide ( PT /Cy‐haplo) now predominates …
post‐transplantation high‐dose cyclophosphamide ( PT /Cy‐haplo) now predominates …
Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia
…, A Hirose, M Nakamae, T Nakane, H Nakamae… - Infection, 2014 - Springer
Purpose Although a few prospective studies have addressed the question as to which biomarker
of infection in adult patients with febrile neutropenia (FN) is superior, procalcitonin (PCT…
of infection in adult patients with febrile neutropenia (FN) is superior, procalcitonin (PCT…
[HTML][HTML] HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory …
H Nakamae, H Koh, T Katayama, M Nishimoto… - Experimental …, 2015 - Elsevier
… H Nakamae received travel/accommodations/meeting expenses from Otsuka Pharmaceutical
Co., Astellas Pharma, and Chugai Pharmaceutical Co. M Nishimoto received travel/…
Co., Astellas Pharma, and Chugai Pharmaceutical Co. M Nishimoto received travel/…
Clinical characteristics, prognostic factors, and outcomes of patients with essential thrombocythemia in Japan: the JSH-MPN-R18 study
Y Hashimoto, T Ito, A Gotoh, M Nakamae… - International journal of …, 2022 - Springer
We conducted a large-scale, nationwide retrospective study of Japanese patients who were
diagnosed with essential thrombocythemia based on the diagnostic criteria in the World …
diagnosed with essential thrombocythemia based on the diagnostic criteria in the World …
Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders
…, A Hirose, M Nakamae, M Hino, H Nakamae - Journal of Infection and …, 2016 - Elsevier
… Hashiba b , Ayumi Sato b , Masatomo Kuno a , Yosuke Makuuchi a , Teruto Takakuwa a ,
Hiroshi Okamura a , Asao Hirose a , Mika Nakamae a , Masayuki Hino a , Hirohisa Nakamae a …
Hiroshi Okamura a , Asao Hirose a , Mika Nakamae a , Masayuki Hino a , Hirohisa Nakamae a …